19 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
additional restrictions on the marketing and promotion of the product, or we may be required to recall the product or implement changes to the way … or a requirement that we initiate a product recall; and
injunctions or the imposition of civil or criminal penalties.
Additionally, if ABP-450
8-K
EX-99.3
mm0rem om21e22oyp
19 Oct 23
AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine
4:23pm
8-K
EX-99.1
9vumny4bqccx7tap29n
24 Jul 23
Corporate Presentation July 2023
6:43am
425
EX-99.1
l3cokc zlcuhughc3
23 May 23
Business combination disclosure
9:39pm
8-K
EX-99.1
84xt26526yy32 zw
23 May 23
Corporate Presentation May 2023
9:38pm
DEFM14A
67szyu5w0jhlanwt9
12 May 23
Proxy related to merger
5:00pm
424B3
gvi4 oisx
12 May 23
Prospectus supplement
4:33pm
S-4
EX-10.15
cyohbay 8dqtg93i
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
S-4
shfcw ewthmmer6c1jfs
23 Dec 22
Registration of securities issued in business combination transactions
6:28pm
- Prev
- 1
- Next